The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
Sodium ethyl((4-(3'-((7H-purin-6-yl)carbamoyl)-[1,1'-biphenyl]-3-yl)-1H-imidazol-1-yl)methyl)phosphonate ID: ALA4549109
PubChem CID: 155549404
Max Phase: Preclinical
Molecular Formula: C24H21N7NaO4P
Molecular Weight: 503.46
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCOP(=O)([O-])Cn1cnc(-c2cccc(-c3cccc(C(=O)Nc4ncnc5nc[nH]c45)c3)c2)c1.[Na+]
Standard InChI: InChI=1S/C24H22N7O4P.Na/c1-2-35-36(33,34)15-31-11-20(29-14-31)18-7-3-5-16(9-18)17-6-4-8-19(10-17)24(32)30-23-21-22(26-12-25-21)27-13-28-23;/h3-14H,2,15H2,1H3,(H,33,34)(H2,25,26,27,28,30,32);/q;+1/p-1
Standard InChI Key: KEMRPCYWDSBUSZ-UHFFFAOYSA-M
Molfile:
RDKit 2D
37 40 0 0 0 0 0 0 0 0999 V2000
16.4549 -10.9441 0.0000 Na 0 0 0 0 0 15 0 0 0 0 0 0
16.0786 -10.2507 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.7094 -14.9859 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5846 -16.2287 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4166 -14.5692 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3399 -12.0311 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2559 -11.2617 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4550 -15.8297 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3703 -10.6626 0.0000 P 0 0 0 0 0 0 0 0 0 0 0 0
15.3662 -9.8418 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.1663 -16.2347 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.8731 -15.0041 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5549 -10.5849 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6933 -13.3441 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8737 -15.8228 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6848 -12.5231 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2988 -15.8180 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2935 -14.9928 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7114 -11.4089 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.1613 -14.5939 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0012 -14.5754 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0768 -11.2532 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.0703 -8.6088 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0744 -9.4298 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9890 -13.7589 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1587 -13.7730 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.0133 -12.0449 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.5780 -14.5864 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4523 -15.0088 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.1691 -17.0612 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4114 -13.7474 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4568 -17.4745 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.7418 -17.0622 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7427 -16.2415 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9624 -15.9869 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.4792 -16.6504 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9609 -17.3149 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16 6 2 0
22 7 1 0
11 8 2 0
9 19 2 0
27 16 1 0
8 34 1 0
10 24 1 0
24 23 1 0
12 15 2 0
21 3 2 0
18 21 1 0
20 12 1 0
4 17 2 0
9 10 1 0
3 5 1 0
15 4 1 0
22 13 1 0
20 26 2 0
25 21 1 0
30 11 1 0
31 14 1 0
18 28 2 0
14 25 2 0
13 9 1 0
2 9 1 0
5 31 2 0
29 20 1 0
6 22 1 0
17 18 1 0
8 29 1 0
33 32 1 0
7 27 2 0
14 16 1 0
32 30 2 0
28 12 1 0
33 34 2 0
34 35 1 0
35 36 1 0
36 37 2 0
37 33 1 0
M CHG 2 1 1 2 -1
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 503.46Molecular Weight (Monoisotopic): 503.1471AlogP: 4.32#Rotatable Bonds: 8Polar Surface Area: 147.91Molecular Species: ACIDHBA: 8HBD: 3#RO5 Violations: 1HBA (Lipinski): 11HBD (Lipinski): 3#RO5 Violations (Lipinski): 2CX Acidic pKa: 1.41CX Basic pKa: 5.72CX LogP: 0.54CX LogD: 0.55Aromatic Rings: 5Heavy Atoms: 36QED Weighted: 0.27Np Likeness Score: -0.88
References 1. Guillon R, Rahimova R, Preeti, Egron D, Rouanet S, Dumontet C, Aghajari N, Jordheim LP, Chaloin L, Peyrottes S.. (2019) Lead optimization and biological evaluation of fragment-based cN-II inhibitors., 168 [PMID:30798051 ] [10.1016/j.ejmech.2019.02.040 ]